Incidence of retinal artery occlusion following intravitreal antivascular endothelial growth factor injections

Acta Ophthalmol. 2019 Sep;97(6):e938-e939. doi: 10.1111/aos.14058. Epub 2019 Feb 27.

Authors

Xinxiao Gao^{1

2}, Durga Borkar¹, Anthony Obeid¹, Jason Hsu¹, Allen C Ho¹, Sunir J Garg¹

Affiliations

¹ The Retina Service of Wills Eye Hospital, Mid Atlantic Retina, Philadelphia, Pennsylvania, USA.
² Beijing Anzhen Hospital, Capital Medical University, Beijing, China.

PMID: 30810272
DOI: 10.1111/aos.14058

No abstract available

Publication types

Letter

MeSH terms

Adult
Aged
Aged, 80 and over
Angiogenesis Inhibitors / administration & dosage
Angiogenesis Inhibitors / adverse effects
Bevacizumab / administration & dosage
Bevacizumab / adverse effects*
Female
Follow-Up Studies
Humans
Incidence
Intravitreal Injections
Macular Degeneration / drug therapy
Male
Middle Aged
Ranibizumab / administration & dosage
Ranibizumab / adverse effects*
Retinal Artery Occlusion / chemically induced
Retinal Artery Occlusion / epidemiology*
Retrospective Studies
United States / epidemiology
Vascular Endothelial Growth Factor A / antagonists & inhibitors
Young Adult

Substances

Angiogenesis Inhibitors
Vascular Endothelial Growth Factor A
Bevacizumab
Ranibizumab